Menopause

Menopause is a natural and permanent stage in a woman's life, defined as the cessation of menstruation resulting from the loss of ovarian follicular activity. It is clinically diagnosed after 12 consecutive months without a menstrual period, provided there is no other obvious pathological or physiological cause. This transition typically occurs as a normal part of aging, with the average age being 51 years in developed countries. The period leading up to menopause is called perimenopause, characterized by irregular menstrual cycles and the onset of symptoms as ovarian function declines. The time after the final menstrual period is known as postmenopause. While natural menopause is a physiological process, menopause can also be induced by medical interventions like chemotherapy or pelvic radiation therapy, or by surgical removal of both ovaries (bilateral oophorectomy). The primary cause of natural menopause is the gradual depletion of ovarian follicles, leading to decreased production of hormones such as estrogen. Managing symptoms to improve quality of life and implementing preventive strategies to reduce the risk of long-term complications like osteoporosis and cardiovascular disease are key aspects of care during and after this transition. With appropriate lifestyle modifications, screening, and medical management where indicated, women can maintain a high quality of life and good health long after menopause.

Symptoms

Hot flushes (flashes)
Night sweats
Vaginal dryness, burning, or irritation
Painful intercourse (dyspareunia)
Urinary urgency, frequency, or nocturia
Recurrent urinary tract infections (UTIs)
Insomnia and other sleep disturbances
Mood swings, irritability, anxiety, or low mood
Joint and muscle pain (arthralgia/myalgia)
Irregular menstrual cycles (shorter, longer, heavier, lighter) during perimenopause
Difficulty with memory or concentration ('brain fog')
New onset or change in pattern of headaches/migraines
Palpitations (sensation of a racing or pounding heart)
Skin dryness, itching, or formication (sensation of insects crawling)
Reduced libido (decreased sexual desire)
Thinning hair on the scalp
Increased facial hair
Burning mouth syndrome
Dizziness
Tinnitus
Postmenopausal bleeding (any vaginal bleeding after 12 months of amenorrhea, requires urgent investigation)
Unexplained weight loss (requires urgent investigation)
Persistent pelvic pain or bloating (requires urgent investigation)
New onset severe depression or suicidal ideation (requires urgent investigation)

Causes & Risk Factors

Natural depletion of ovarian follicles with age, leading to decreased estrogen and inhibin production (Physiological/Natural Menopause)
Surgical removal of both ovaries (bilateral oophorectomy), causing abrupt and immediate cessation of ovarian hormone production (Surgical/Induced Menopause)
Chemotherapy, particularly alkylating agents, which can damage the ovaries and induce menopause (Medical/Iatrogenic Menopause)
Pelvic radiation therapy, which can destroy ovarian follicles (Medical/Iatrogenic Menopause)
Gonadotropin-releasing hormone (GnRH) agonists, used to treat conditions like endometriosis or fibroids, which induce a temporary, reversible menopausal state (Medical/Iatrogenic Menopause)
Genetics/Family History (age at menopause is strongly genetically determined)
Chromosomal Abnormalities (e.g., Turner syndrome, Fragile X premutation carriers)
Autoimmune Diseases (e.g., Addison's disease, thyroid disease)
Smoking (smokers may experience menopause 1-2 years earlier than non-smokers)
Medical treatments such as chemotherapy or pelvic radiation therapy
Surgical history, specifically bilateral oophorectomy (causes immediate menopause)
Hysterectomy (may hasten menopause by 1-2 years even with ovarian conservation, possibly due to altered blood supply)
Low Body Mass Index (BMI) (possible risk factor for earlier onset or increased symptom severity)
Nulliparity (possible risk factor for earlier onset or increased symptom severity)
Epilepsy (possible risk factor for earlier onset or increased symptom severity)
Lower socioeconomic status (associated with earlier menopause)
Multiparity (protective factor for later onset of menopause)
Higher BMI (protective factor for later onset of menopause due to peripheral estrogen production in adipose tissue)

Diagnosis

Clinical diagnosis in women over 45 years who have not had a period for at least 12 consecutive months and are not using hormonal contraception.
Diagnosis of perimenopause based on vasomotor symptoms and irregular periods.
Detailed menstrual history, including date of last menstrual period (LMP), cycle length, and regularity.
Comprehensive symptom review, assessing the onset, severity, and impact of vasomotor, urogenital, psychological, and other symptoms.
Review of medical and surgical history, including any hysterectomy, oophorectomy, chemotherapy, or pelvic radiation.
Family history, particularly the age of maternal menopause.
Consideration of contraceptive history, as hormonal contraception can mask the signs of perimenopause/menopause.
Physical examination is generally not required for diagnosis unless other pathology is suspected; may include blood pressure, BMI, breast examination, or pelvic examination (if GSM symptoms or postmenopausal bleeding are present).
Follicle-Stimulating Hormone (FSH) blood test is not routinely recommended for diagnosis in women over 45.
FSH blood test can be considered to help diagnose menopause in women aged 40-45 with menopausal symptoms, including a change in their menstrual cycle.
FSH blood test should be used to diagnose premature ovarian insufficiency (POI) in women under 40 with suspected menopausal symptoms (two elevated FSH levels >25 IU/L drawn 4-6 weeks apart are typically diagnostic).
Estradiol levels decrease but fluctuate significantly during perimenopause and are not reliable for diagnosis.
Thyroid-Stimulating Hormone (TSH) test may be performed to rule out thyroid disorders, which can mimic menopausal symptoms.
Imaging, such as transvaginal ultrasound, is not used for the diagnosis of menopause itself but may be used to investigate postmenopausal bleeding or other pelvic symptoms.
Differential diagnosis includes hyperthyroidism or hypothyroidism, hyperprolactinemia, pregnancy, depression/anxiety disorders, medication side effects (e.g., from SSRIs, tamoxifen), and malignancy (e.g., carcinoid syndrome, lymphoma).

Treatment Options

Treatment should be individualized based on symptom severity, patient preference, and personal risk profile.
Menopausal Hormone Therapy (MHT/HRT) is the most effective treatment for vasomotor symptoms and can help prevent osteoporosis.
The benefits of MHT are generally considered to outweigh the risks for most healthy, symptomatic women who are aged younger than 60 years or who are within 10 years of menopause onset.
For genitourinary syndrome of menopause (GSM) symptoms not relieved by non-hormonal lubricants/moisturizers, low-dose vaginal estrogen is recommended.
Lifestyle modifications include a balanced diet rich in calcium and vitamin D, regular weight-bearing and muscle-strengthening exercise, smoking cessation, and limiting alcohol intake.
Symptom management strategies include wearing layers of clothing, using fans, and avoiding triggers for hot flushes (e.g., spicy food, caffeine).
Stress management techniques such as mindfulness, yoga, or cognitive behavioral therapy (CBT) can be considered for low mood or anxiety associated with menopause.
Systemic Estrogen (oral, transdermal patches, gels, sprays) is used for vasomotor and other systemic symptoms; requires a progestogen for endometrial protection in women with a uterus.
Progestogens (oral micronized progesterone, intrauterine system) are co-prescribed with systemic estrogen for women with a uterus, given cyclically or continuously.
Tibolone, a synthetic steroid with estrogenic, progestogenic, and androgenic properties.
Tissue-Selective Estrogen Complex (TSEC), such as conjugated estrogens/bazedoxifene.
Local Estrogen Therapy (vaginal creams, tablets, pessaries, rings) is used for isolated GSM symptoms, with very low systemic absorption.
Non-hormonal prescription medications include SSRIs/SNRIs (e.g., paroxetine, venlafaxine, escitalopram) which are effective for vasomotor symptoms.
Gabapentin, an anticonvulsant, is effective for night sweats.
Clonidine, an antihypertensive, can provide modest relief from vasomotor symptoms.
Ospemifene, a selective estrogen receptor modulator (SERM), is used for treating moderate to severe dyspareunia.
Fezolinetant, a neurokinin 3 (NK3) receptor antagonist, is a newer non-hormonal drug specifically for vasomotor symptoms.
Treatment should be reviewed 3 months after starting MHT and annually thereafter, unless clinical reasons require an earlier review.
Referral to a specialist may be indicated for diagnostic uncertainty, contraindications to MHT, complex medical history, persistent problematic side effects, no improvement in symptoms with treatment, or investigation of red flag symptoms like postmenopausal bleeding.

Frequently Asked Questions

How do I know if I am in perimenopause or menopause?

Menopause is diagnosed after 12 consecutive months without a period, without other obvious causes. Perimenopause is the transitional period leading up to menopause, characterized by irregular periods and symptoms like hot flushes. For women over 45, diagnosis is usually clinical, based on your symptoms and menstrual history, without routine blood tests.

Is hormone replacement therapy (MHT/HRT) safe for me?

Menopausal Hormone Therapy (MHT) is generally considered safe and effective for most healthy, symptomatic women who are aged younger than 60 years or who are within 10 years of menopause onset. Your doctor will discuss your individual health history and risk factors to determine if MHT is appropriate for you.

What are the main risks and benefits of taking MHT?

The main benefits of MHT include effective relief of vasomotor symptoms (hot flushes, night sweats) and prevention of osteoporosis. Risks vary by individual and type of MHT, and your doctor will discuss these with you, considering factors like your age, time since menopause, and medical history.

How long will my hot flushes last?

Hot flushes are most common in late perimenopause and early postmenopause. The median duration is approximately 7.4 years, but they can persist for more than a decade in some women.

What are the non-hormonal options for managing hot flushes?

Non-hormonal options include lifestyle changes like wearing layers, using fans, and avoiding triggers (e.g., spicy food, caffeine). Prescription medications such as certain SSRIs/SNRIs (e.g., paroxetine, venlafaxine), gabapentin, clonidine, and the newer drug fezolinetant can also be effective.

Why am I gaining weight, especially around my middle?

After menopause, many women experience changes in body composition, including a tendency to gain central (abdominal) fat. This is partly due to hormonal changes and can be a risk factor for metabolic syndrome. Regular exercise and a balanced diet are important for managing weight.

Is it normal to have very heavy or irregular periods during perimenopause?

Yes, irregular periods, including shorter, longer, heavier, or lighter cycles, are common during perimenopause as ovarian function becomes erratic and hormone levels fluctuate. However, any concerning changes should be discussed with your doctor to rule out other causes.

What can I do about vaginal dryness and painful sex?

For vaginal dryness and painful sex (dyspareunia), non-hormonal lubricants and vaginal moisturizers can provide relief. If these are not sufficient, low-dose local vaginal estrogen therapy is highly effective and has very low systemic absorption. Ospemifene, a non-hormonal prescription medication, is also available for moderate to severe dyspareunia.

Is it safe to use vaginal estrogen long-term?

Low-dose vaginal estrogen therapy for genitourinary syndrome of menopause (GSM) has very low systemic absorption and is generally considered safe for long-term use, even in women who may not be candidates for systemic MHT. Your doctor will discuss the appropriateness for your individual situation.

Does menopause cause depression or anxiety?

Mood changes, including mood swings, irritability, anxiety, and low mood, are common during perimenopause and menopause. While not always directly caused by hormonal changes, they can be exacerbated by them and by poor sleep. Cognitive behavioral therapy (CBT) can be considered for low mood or anxiety associated with menopause.

Why is my memory so bad? Is 'brain fog' real?

Many women report cognitive changes, such as difficulty with memory or concentration, often described as 'brain fog,' during perimenopause and menopause. This is a recognized symptom, though the precise link to hormonal changes and long-term cognitive decline is an area of ongoing research.

What is the difference between systemic MHT and local vaginal estrogen?

Systemic MHT delivers hormones throughout your body to treat widespread symptoms like hot flushes and night sweats. Local vaginal estrogen therapy delivers a very low dose of estrogen directly to the vaginal area to treat symptoms like dryness, burning, and painful intercourse, with minimal absorption into the bloodstream.

Do I need a progestogen if I have had a hysterectomy?

If you have had a hysterectomy (removal of your uterus), you typically do not need to take a progestogen with systemic estrogen therapy. Progestogens are primarily used to protect the uterine lining from overgrowth caused by estrogen.

How long should I stay on MHT?

The duration of MHT use is individualized. Your doctor will review your treatment at 3 months after starting and annually thereafter. The benefits of MHT are generally considered to outweigh the risks for most healthy, symptomatic women who are aged younger than 60 years or who are within 10 years of menopause onset. Decisions about continuing MHT should be made in consultation with your healthcare provider.

What happens when I stop taking MHT?

When you stop taking MHT, some menopausal symptoms, particularly vasomotor symptoms like hot flushes, may return. Your doctor can help you develop a plan for safely discontinuing MHT, potentially by gradually reducing the dose.

Does menopause increase my risk of heart disease or osteoporosis?

Yes, the risk of cardiovascular disease (CVD) increases after menopause, partly due to changes in lipid profiles and vascular function associated with estrogen loss. Estrogen deficiency also leads to accelerated bone density loss, significantly increasing the risk of osteoporosis and fragility fractures.

What supplements, like calcium and vitamin D, should I be taking?

Adequate intake of calcium (approximately 1200 mg/day) and vitamin D (800-1000 IU/day) is recommended for bone health during and after menopause. Your doctor can advise on whether supplements are necessary based on your dietary intake and individual needs.

Are bioidentical hormones safer or more effective than standard MHT?

The dossier does not provide specific information comparing bioidentical hormones to standard MHT. However, standard MHT formulations are regulated and have established safety and efficacy profiles. Discuss any concerns about hormone therapy with your healthcare provider.

What can I do about my low libido?

Reduced sexual desire (low libido) can be a symptom of menopause. Addressing other menopausal symptoms like vaginal dryness with local estrogen therapy can often improve comfort and desire. Discussing this with your healthcare provider can help identify underlying causes and appropriate management strategies.

When should I be concerned about bleeding after menopause?

Any vaginal bleeding after 12 consecutive months of amenorrhea (postmenopausal bleeding) is considered a 'red flag' symptom and requires urgent investigation by a healthcare professional to rule out endometrial pathology, including cancer.

Can I still get pregnant during perimenopause?

While fertility declines significantly during perimenopause, it is still possible to become pregnant until you have officially reached menopause (12 consecutive months without a period). If you wish to avoid pregnancy, contraception is still necessary during this time.

How does MHT affect my risk of breast cancer?

The relationship between MHT and breast cancer risk is complex and depends on factors like the type of MHT, duration of use, and individual risk factors. Your doctor will discuss this as part of your personalized risk assessment when considering MHT.